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Background: Ramsay Hunt Syndrome (RHS) is a rare, severe complication of varicella zoster virus (VZV) reactivation
in the geniculate ganglion. Facial paralysis is one of the features and without treatment, it fully recovers in as little
as 20% of cases; this is much improved if treatment is started within 72 hours. This case is noteworthy in that
coexistence of facial palsy with cervical dermatome involvement by VZV is not typical of RHS. Yet, it has been
reported before.
Case presentation: A 54 year old Caucasian woman presented with right ear discomfort, difficulty hearing and a
vesicular rash along the pinnae, 8 days after the eruption of a similar rash in the right C2-C4 dermatomes.
2 days later, she awoke with a partial right-sided facial paralysis, which improved with treatment (valacyclovir and
prednisone).
Conclusions: This case is most pertinent to Family Practice, Otolaryngology and Neurology. It highlights the possible
co-existence of RHS with cervical VZV reactivation and encourages physicians to monitor for this complication even
before geniculate ganglion reactivation occurs. RHS is a rare disease that can present with vague symptoms. A high
index of suspicion and close follow up are essential. Early intervention with antivirals and corticosteroids has shown
significantly improved outcomes in these patients.
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Ramsay Hunt Syndrome (RHS), also called Herpes Zoster
Oticus, is a rare, severe complication of varicella zoster
virus (VZV) reactivation. The classic triad consists of
otalgia, vesicles in the auditory canal and ipsilateral
facial paralysis [1]. Without treatment, full recovery of
the facial paralysis occurs in as little at 20% of cases; this
is much improved if treatment is started within 72 hours
[2]. The risk of RHS in VZV reactivation has been quoted
as little as 0.2% at day 60 [3]. However, the long-term
morbidity that may result from RHS makes this an
important topic of discussion. This case is noteworthy in
that coexistence of facial palsy with cervical dermatome
involvement of VZV is not typical of RHS. The aim of this
article is to inform physicians about the presentation,
including atypical, and management of RHS in order to
facilitate prompt diagnosis, treatment and appropriate
specialist referral.* Correspondence: mali.worme@gmail.com
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A 54-year-old Caucasian female, with no past medical
history, developed right-sided neck pain on day 1. On
day 4, an erythematous, vesicular rash erupted at the site
of pain. She was diagnosed with contact dermatitis at a
walk-in clinic. Over days 4–9, she developed a right
earache and headache and the rash spread to her upper
right chest-wall. The rash was described as “dull and
achy with intermittent sharp pain”. On day 9, at the
family doctor’s office, exam showed an erythematous,
vesicular eruption on the right anterior chest, neck and
shoulder (C2, C3 and C4 dermatomes). The rash halted
at the midline (Figure 1). It was tender, warm and
blanched when palpated. The patient was diagnosed with
herpes zoster (HZ) and secondary cellulitis. Valacyclovir,
cephalexin and acetaminophen were started. On day 12,
she returned with right ear discomfort and difficulty
hearing. Exam showed a similar rash along the auricle but
the external auditory canal was normal. Nortryptyline was
started for neuralgia. On day 14, she woke up with partial
right-sided facial paralysis. In the Emergency Room, RHSLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The sharp midline delineation of the patient’s rash
on day 24.
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prednisone started. A neuro-ophthalmology referral was
made. On day 46, the patient returned showing significant
improvement. She could smile symmetrically and close
her right eye completely.
Epidemiology of RHS
The Center for Disease control estimates that 32% of
people in the USA will have HZ during their lifetime [4].
The most important risk factor is increasing age. RHS
has a much lower incidence, presenting in only 0.2% of
all HZ cases [3,5]. After primary VZV infection, the
virus can remain dormant in sensory dorsal root ganglia.
Reactivation causes HZ (shingles) - a painful, ipsilateral,
vesicular eruption in a limited dermatomal distribution.
Pain may precede the vesicles. In RHS, VZV reactivates in
the geniculate ganglion, causing peripheral facial paralysis,
otalgia and auricular vesicles [1]. Late diagnosis is common.
The vesicles may appear after facial paralysis in a minority
of cases (14% of cases in the only prospective study done)
[6]. This means that a proportion of patients diagnosed
with Bell’s palsy actually have RHS sine herpete. Cervical
involvement of herpes zoster is rare with RHS and there-
fore makes this case one of special interest. As RHS is a
reactivation of VZV in the geniculate nucleus, the etiology
of co-existent cervical dermatome involvement is not well
understood. Three theories have been hypothesized [7].
One such theory is that of cerebrospinal fluid (CSF)/
hematogenous spread. In one study, pleocytosis in the
CSF was seen in 38% of cutaneous herpes zoster cases [8].
Moreover, Haanpaa et al. isolated VZV in the CSF of 21%
of patients with cutaneous lesions, but without meningeal
or encephalitis symptoms [9]. Additionally, viremia is a
common occurrence during zoster [10]. Since VZV has
been documented in both blood and CSF during herpeszoster, these routes of spread could account for co-existent
multi-dermatome involvement in HZ. Another theory is
interneuronal communication. Brown et al. have shown
that the second to fourth cervical nerves of the cervical
plexus interconnect with peripheral branches of the facial
nerve in some individuals [11]. Numerous interconnec-
tions between the lower cranial nerves and upper cervical
nerves have also been illustrated. These linkages are highly
variable amongst individuals [12]. It is plausible that VZV
and associated inflammation may spread from a primary
site of reactivation, through these anastomoses. Finally, the
simultaneous activation of multiple ganglia may occur and
could account for this clinical picture. Physicians should
assess for immunocompromised states when patients
present with multi-dermatomal VZV reactivation.
Diagnosis of RHS
Ramsay Hunt Syndrome is diagnosed clinically and is
based on unilateral facial weakness plus vesicular lesions
in the ipsilateral ear, hard palate or anterior 2/3 of the
tongue [6]. Facial weakness is identified by facial drooping,
a widened palpebral fissure and decreased smile on the
affected side (Figure 2). The associated pain is described
as dull and aching with associated allodynia. Otalgia or
vertigo completes the triad picture of RHS. The individual
symptoms of RHS are non-specific and can be seen in
other diseases; the differential is described in Table 1.
Some 2-23% of unilateral facial palsies without vesicles are
actually herpes zoster sine herpete [13]. Therefore lesions
are not required for diagnosis of RHS [6]. The traditional
diagnostic triad of RHS cannot be applied to the atypical
presentations of RHS, including multiple nerve involve-
ment as seen in this case [14]. The use of CSF analysis or
MRI adds no additional diagnostic value [15]. Finally,
the gold standard for diagnosing VZV reactivation is
polymerase chain reaction of skin, saliva or middle ear
fluid samples but this is rarely done clinically [16].
Complications of RHS
1. Corneal abrasions and ulcers, if eye-lid closure
is impaired
2. Secondary infection with bacteria (cellulitis)
3. Postherpetic neuralgia, as with other Varicella
Zoster virus reactivations
4. Permanent facial paralysis
5. Long term ipsilateral hearing loss and tinnitus
Management of RHS
Pharmacologic treatment of HZ complicated by RHS is
controversial and requires ongoing research. Antivirals and
corticosteroids are the current mainstay of treatment.
Acyclovir, valacyclovir and famcyclovir have been shown to
reduce the duration of acute HZ symptoms and associated
Figure 2 RHS signs: vesicular lesions in the ear, facial drooping, widened palpebral fissure and decreased smile.
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and are Food and Drug Administration (FDA) approved
first line therapies for HZ [20]. They are also used in RHS.
In addition, the potent anti-inflammatory effect of steroids
has been argued to enhance recovery in RHS by reducing
the inflammation and edema of the facial nerve, thus
reducing damage [21].
Steroids
There is a paucity of published data on the efficacy of
corticosteroids in RHS specifically. A Cochrane Review
found no randomized controlled trials investigating the
use of corticosteroids as in Ramsay Hunt syndrome [22].
Yet, large RCTs showed that adjunct corticosteroids
resulted in quicker healing of the rash and decreased
incidence and severity of pain during HZ. Yet, there was
no reduction in the incidence or severity of post herpetic
neuralgia in these studies [20,23].
Steroids and antivirals
A Cochrane Review of the sole randomized controlled
trial (RCT) comparing treatment with antivirals and
corticosteroids to corticosteroids alone in 15 RHS patients
showed no significant difference in outcomes [24]. A
subsequent meta-analysis of 12 RHS articles concludedTable 1 Differential diagnosis of Ramsay hunt syndrome
Differential diagnosis Features
1/Bell’s palsy Bell’s palsy is a diagnosis of exc
otalgia suggest Ramsay Hunt.
2/Otitis externa The ear pain in RHS can be mista
Ramsay Hunt from otitis.
3/Trigeminal neuralgia Trigeminal neuralgia pain is simi
It is not associated with any skinthat antiviral therapy plus steroids compared to steroids
alone significantly improved facial nerve function recovery
(odds ratio of 2.8, 95% Confidence Interval (CI)) [25].
The largest RHS treatment study was a retrospective
analysis of 80 cases. Patients treated with acyclovir and
prednisone within 72 hours of symptom onset had a
complete recovery rate of 75% vs those treated after
7 days, who had a complete recovery rate of 30% [16]. In
addition, 50% of patients who were not treated in the
first 3 days went on to have a complete loss of response
to facial nerve stimulation.Adjuvant treatment
Eye patches, taping the eye closed, artificial tears and
oral analgesics are also used in the management of RHS.
Despite the absence of RCTs on RHS management,
when considering the possibility of lifelong facial paralysis
and hearing loss, experts recommend combination antiviral
and corticosteroid therapy within the first 72 h of symp-
toms [6,16]. Though no set-dosing regimen exists, 800 mg
acyclovir 5 times/day for 7–10 days and Prednisone 1 mg/
kg for 5 days and taper is used in published trials. In our
case, acyclovir was replaced by 1 g valacyclovir TID for
10 days, with successful outcomes.lusion for unilateral facial weakness [17]. Erythematous vesicular rash and
ken for otitis [18]. Onset of rash and development of facial palsy differentiate
lar to Ramsay Hunt but tends to be paroxysmal and stimulated by triggers.
manifestations or neurological losses [19].
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Ramsay Hunt syndrome is a rare disease that can present
with vague symptoms and atypical presentations as seen
in this case with cervical dermatome involvement. A high
index of suspicion and close follow up are essential in
patients who have HZ symptoms. Early intervention with
antivirals and corticosteroids has shown to significantly
improve outcomes in these patients.
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